BNP Paribas Financial Markets
SRRA

BNP Paribas Financial Markets’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

BNP Paribas Financial Markets’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3
Closed -$189 – 4220
2016
Q3 		$189 Hold
3
– – ﹤0.01% 3498
2016
Q2 		$207 Hold
3
– – ﹤0.01% 3512
2016
Q1 		$694 Sell
3
-7
-70% -$2.23K ﹤0.01% 2535
2015
Q4 		$5.9K Hold
10
– – ﹤0.01% 3445
2015
Q3 		$7.98K Buy
+10
New +$11.3K ﹤0.01% 3448

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BNP Paribas Financial Markets's SRRA Position: Q4 2016 in Review

BNP Paribas Financial Markets sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q4 2016, closing a stake of 3 shares — an estimated $189 sold.

BNP Paribas Financial Markets first reported a position in SRRA in Q3 2015 and held it in 5 quarters. The position peaked at $7.98K in Q3 2015. 36 funds tracked by Wall St. Rank hold SRRA as of Q4 2016.

  • BNP Paribas Financial Markets reported no remaining Sierra Oncology, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 3 Sierra Oncology, Inc. Common Stock shares in Q4 2016, an estimated $189.
  • BNP Paribas Financial Markets first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 5 quarters.
  • BNP Paribas Financial Markets's Sierra Oncology, Inc. Common Stock position peaked at $7.98K in Q3 2015.
  • 36 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q4 2016.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2016, filed 14 Feb 2017.